Dialysis News and Research

Latest Dialysis News and Research

State roundup: Calif. doc supply strains under health law

The compelling facts and figures he provided the Senate Finance Committee gave feuding Democrats and Republicans the confidence to unite behind an expedited but cautious roadmap toward a federally prescribed expansion of Medicaid in Virginia.

12 Feb 2013

WetAlert wireless wetness detector from Fresenius Medical Care

Fresenius Medical Care, the world's largest provider of dialysis products and services, announced today its introduction of the WetAlert wireless wetness detector, designed to detect venous needle displacement and prevent blood loss for dialysis patients at home.

11 Feb 2013

Frequent hemodialysis can cause vascular complications in patients

Compared with standard dialysis, frequent dialysis can cause complications related to repeated access to the blood, requiring patients to undergo more repair procedures to the site through which blood is removed and returned, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

10 Feb 2013

Omega-3 fatty acids can prevent sudden cardiac death in dialysis patients

Medical literature long has touted the benefits of omega-3 fatty acids for the heart. But until now, researchers have not studied the potential benefit for people on hemodialysis, who are among the highest-risk patients for sudden cardiac death.

9 Feb 2013

ZOLL's Intravascular Temperature Management solution receives Shonin approval in Japan

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, has received Shonin approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) to enter the Japanese market with its Intravascular Temperature Management (IVTM) technology—the first intravascular temperature management system to receive Shonin approval in Japan.

6 Feb 2013

Chem-Aqua, Nephros partner to distribute new ultrafilters in North America

Nephros, Inc. and Chem-Aqua, Inc., a wholly owned water treatment subsidiary of NCH Corporation, announced today that the companies have signed a non-exclusive distributor agreement for Chem-Aqua to distribute Nephros's innovative ultrafilters in North America.

4 Feb 2013

Medicare expands competitive bidding program

The new prices will kick in July 1 and are expected to save on average 45 percent for products such as walkers, wheelchairs, oxygen equipment and other medical products.

2 Feb 2013

African-Americans without private health insurance less likely to receive kidney transplants

African-Americans and individuals without private health insurance are less likely than others to receive a kidney transplant before requiring dialysis, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).

1 Feb 2013

Velomedix commences rapid therapeutic hypothermia system pilot study in heart attack

Velomedix, a venture-backed medical device company advancing the field of therapeutic hypothermia, today announced the enrollment of the first patient in its VELOCITY pilot study.

31 Jan 2013

Delaware District Court rules in favor of Pfizer in RAPAMUNE patent case

Pfizer Inc. said today that the United States District Court for the District of Delaware ruled that Pfizer's patent covering a method for using sirolimus, the active ingredient in RAPAMUNE®, for the inhibition of organ transplant rejection is valid and infringed.

31 Jan 2013

First Edition: January 31, 2013

Today's headlines include reports on a new health law final rule issued by the Internal Revenue Service eligibility and affordability standards for insurance subsidies.

31 Jan 2013

Keryx prices underwritten public offering of common stock

Keryx Biopharmaceuticals, Inc. today announced the pricing of its previously announced underwritten public offering of common stock consisting of 8,234,000 shares at $8.49 per share.

30 Jan 2013

FDA approves Genzyme’s KYNAMRO to treat homozygous familial hypercholesterolemia

Genzyme, a Sanofi company, and Isis Pharmaceuticals Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for KYNAMROTM (mipomersen sodium) injection.

30 Jan 2013

NSAIDs pose kidney risk in some children

A small but significant percentage of children develop acute kidney injury after taking nonsteroidal anti-inflammatory drugs such as ibuprofen, show study findings published in the Journal of Pediatrics.

29 Jan 2013

Lawmakers target fiscal cliff's provision aiding Amgen for elimination

The fiscal cliff legislation approved earlier this month excluded Amgen's Sensipar, which is used by kidney dialysis patients, from Medicare price controls for an additional two years.

28 Jan 2013

New AngioSculpt catheters from AngioScore can treat peripheral artery disease below the knee

AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, today announced the launch of its new 100 mm length AngioSculpt PTA Scoring Balloon Catheters for the treatment of peripheral artery disease (PAD) below the knee (BTK).

28 Jan 2013

First Edition: January 25, 2013

Today's headlines include various state-level reports about how budget issues are impacting health policy decisions.

28 Jan 2013

Ibuprofen and naproxen can cause kidney damage in children

Sick children, especially those with some dehydration from flu or other illnesses, risk significant kidney injury if given drugs such as ibuprofen and naproxen, Indiana University School of Medicine researchers said Friday.

25 Jan 2013

NSAIDs cause acute kidney injury in some children

Non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen, are commonly used to treat pain and reduce fever in children. However, the use of NSAIDs has been shown to cause acute kidney injury (AKI) in some children

25 Jan 2013

Amgen drug gets boost in fiscal cliff legislation

Just two weeks after pleading guilty in a major federal fraud case, Amgen, the world's largest biotechnology firm, scored a largely unnoticed coup on Capitol Hill: Lawmakers inserted a paragraph into the "fiscal cliff" bill that did not mention the company by name but strongly favored one of its drugs.

23 Jan 2013